Power Law company profile

Senda Biosciences

Biotech & Life Sciences · Cambridge, United States · Founded 2017 Colt

Senda Biosciences | Pioneering Intersystems Biology

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

12 investors on Senda Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Flagship Pioneering

Series B+ 11 investors entered at this stage

Alexandria Venture Investments

Partners Investment

Qatar Investment Authority

Stage 1 Ventures

Mint Venture Partners

Terra Magnum Capital Partners

Longevity Vision Fund

Mayo Clinic

Samsung Life Science Fund

Bluwave Capital

State of Michigan Retirement Systems

Global footprint

Where Senda Biosciences has talent and traffic

Workforce by country

🇺🇸 United States · Cambridge HQ

Book a demo for the full country breakdown

Market sentiment

What the market is saying about Senda Biosciences

An AI-synthesized read of the highest-engagement posts about Senda Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Senda Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles